Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

576 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Head and neck cancer radiotherapy amid COVID-19 pandemic: Report from Milan, Italy.
Alterio D, Volpe S, Marvaso G, Turturici I, Ferrari A, Leonardi MC, Lazzari R, Fiore MS, Bufi G, Cattani F, Arrobbio C, Patti F, Casbarra A, Cavallo I, Mastrilli F, Orecchia R, Jereczek-Fossa BA. Alterio D, et al. Among authors: patti f. Head Neck. 2020 Jul;42(7):1482-1490. doi: 10.1002/hed.26319. Epub 2020 Jun 18. Head Neck. 2020. PMID: 32557972 Free PMC article.
Carotid blowout syndrome after reirradiation for head and neck malignancies: a comprehensive systematic review for a pragmatic multidisciplinary approach.
Alterio D, Turturici I, Volpe S, Ferrari A, Russell-Edu SW, Vischioni B, Mardighian D, Preda L, Gandini S, Marvaso G, Augugliaro M, Durante S, Arculeo S, Patti F, Boccuzzi D, Casbarra A, Starzynska A, Santoni R, Jereczek-Fossa BA. Alterio D, et al. Among authors: patti f. Crit Rev Oncol Hematol. 2020 Nov;155:103088. doi: 10.1016/j.critrevonc.2020.103088. Epub 2020 Aug 25. Crit Rev Oncol Hematol. 2020. PMID: 32956946 Review.
Comparing TomoHelical and TomoDirect in postmastectomy hypofractionated radiotherapy after immediate breast reconstruction.
Dicuonzo S, Patti F, Luraschi R, Frassoni S, Rojas DP, Zaffaroni M, Morra A, Gerardi MA, Zerella MA, Emiro F, Cattani F, Bagnardi V, Fodor CI, Veronesi P, Galimberti VE, Orecchia R, Leonardi MC, Jereczek-Fossa BA. Dicuonzo S, et al. Among authors: patti f. Phys Med. 2021 Oct;90:66-72. doi: 10.1016/j.ejmp.2021.09.007. Epub 2021 Sep 23. Phys Med. 2021. PMID: 34563833
Dosimetric Impact of Inter-Fraction Anatomical Changes in Carbon Ion Boost Treatment for High-Risk Prostate Cancer (AIRC IG 14300).
Russo S, Ricotti R, Molinelli S, Patti F, Barcellini A, Mastella E, Pella A, Paganelli C, Marvaso G, Pepa M, Comi S, Zaffaroni M, Avuzzi B, Giandini T, Pignoli E, Valdagni R, Baroni G, Cattani F, Ciocca M, Jereczek-Fossa BA, Orlandi E, Orecchia R, Vischioni B. Russo S, et al. Among authors: patti f. Front Oncol. 2021 Sep 28;11:740661. doi: 10.3389/fonc.2021.740661. eCollection 2021. Front Oncol. 2021. PMID: 34650922 Free PMC article.
Mixed-Beam Approach for High-Risk Prostate Cancer Carbon-Ion Boost Followed by Photon Intensity-Modulated Radiotherapy: Preliminary Results of Phase II Trial AIRC-IG-14300.
Marvaso G, Vischioni B, Pepa M, Zaffaroni M, Volpe S, Patti F, Bellerba F, Gandini S, Comi S, Corrao G, Zerini D, Augugliaro M, Fodor C, Russo S, Molinelli S, Ciocca M, Ricotti R, Valvo F, Giandini T, Avuzzi B, Valdagni R, De Cobelli O, Cattani F, Orlandi E, Jereczek-Fossa BA, Orecchia R. Marvaso G, et al. Among authors: patti f. Front Oncol. 2021 Nov 17;11:778729. doi: 10.3389/fonc.2021.778729. eCollection 2021. Front Oncol. 2021. PMID: 34869026 Free PMC article.
Long-term effectiveness of natalizumab in secondary progressive multiple sclerosis: A propensity-matched study.
Chisari CG, Aguglia U, Amato MP, Bergamaschi R, Bertolotto A, Bonavita S, Morra VB, Cavalla P, Cocco E, Conte A, Cottone S, De Luca G, Di Sapio A, Filippi M, Gallo A, Gasperini C, Granella F, Lus G, Maimone D, Maniscalco GT, Marfia G, Moiola L, Paolicelli D, Pesci I, Ragonese P, Rovaris M, Salemi G, Solaro C, Totaro R, Trojano M, Vianello M, Zaffaroni M, Lepore V, Patti F; Italian MS Register Study Group. Chisari CG, et al. Among authors: patti f. Neurotherapeutics. 2024 May 7:e00363. doi: 10.1016/j.neurot.2024.e00363. Online ahead of print. Neurotherapeutics. 2024. PMID: 38714462 Free article.
ENSEMBLE PLUS: final results of shorter ocrelizumab infusion from a randomized controlled trial.
Hartung HP, Berger T, Bermel RA, Brochet B, Carroll WM, Holmøy T, Karabudak R, Killestein J, Nos C, Patti F, Perrin Ross A, Vanopdenbosch L, Vollmer T, Buffels R, Garas M, Kadner K, Manfrini M, Wang Q, Freedman MS. Hartung HP, et al. Among authors: patti f. J Neurol. 2024 Apr 22. doi: 10.1007/s00415-024-12326-z. Online ahead of print. J Neurol. 2024. PMID: 38649522
576 results